| 2021 | Addition of liver stiffness enhances the predictive accuracy of the PAGE-B model for hepatitis B-related hepatocellular carcinoma | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2023 | Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI-PDFF in NAFLD | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2023 | Comparison of decline in renal function between patients with chronic hepatitis B with or without antiviral therapy | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2020 | Crohn's disease and ulcerative colitis are associated with different lipid profile disorders: a nationwide population-based study | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2022 | Editorial: concurrent fatty liver and chronic viral hepatitis: a dual calamity leading to increased risk of hepatocellular carcinoma? Authors' reply | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2019 | Editorial: effect of hepatic steatosis on liver stiffness in patients with chronic hepatitis B | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2020 | Editorial: tenofovir disoproxil fumarate vs entecavir in patients with chronic hepatitis B and renal impairment-still an open issue | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2020 | Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phase | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2010 | Factors that affect the diagnostic accuracy of liver fibrosis measurement by Fibroscan in patients with chronic hepatitis B. | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2022 | Impact of expanding hepatitis B treatment guidelines: A modelling and economic impact analysis | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2022 | Increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis with concurrent fatty liver | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2020 | Large-scale genome-wide association study identifies HLA class II variants associated with chronic HBV infection: a study from Taiwan Biobank | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2020 | Letter: fatty liver disease could have been a confounding factor for phase change in patients with chronic hepatitis B in the immune-tolerant phase-authors' reply | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2020 | Letter: risk of hepatocellular carcinoma in immune-tolerant phase of chronic hepatitis B-authors' reply | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2023 | Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2006 | Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial
| ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2018 | Predictors of failure to detect early hepatocellular carcinoma in patients with chronic hepatitis B who received regular surveillance | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2023 | Proton pump inhibitor use and the risk of metachronous gastric cancer after H. pylori eradication in patients who underwent endoscopic resection for gastric neoplasms: A population-based cohort study | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2012 | Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2023 | Randomised clinical trial: comparison of tegoprazan and lansoprazole as maintenance therapy for healed mild erosive oesophagitis
| ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2021 | Randomised clinical trial: comparison of tegoprazan and placebo in non-erosive reflux disease
| ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2019 | Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis
| ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2023 | Risk and predictors of hepatic decompensation in grey zone patients by the Baveno VII criteria: A competing risk analysis | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2018 | Sarcopenia is associated with the risk of significant liver fibrosis in metabolically unhealthy subjects with chronic hepatitis B | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2017 | Systematic review with meta-analysis: the efficacy of vonoprazan-based triple therapy on Helicobacter pylori eradication | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2023 | Tenofovir disoproxil fumarate versus tenofovir alafenamide on risk of osteoporotic fracture in patients with chronic hepatitis B: A nationwide claims study in South Korea | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2006 | The effect of sildenafil on segmental oesophageal motility and gastro-oesophageal reflux
| ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
| 2013 | The effects of statins on the clinical outcomes of Clostridium difficile infection in hospitalised patients | ALIMENTARY PHARMACOLOGY & THERAPEUTICS |
